Spatially addressable control of polymerase activity

US2022136021A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022136021-A1
Application numberUS-202017086055-A
CountryUS
Kind codeA1
Filing dateOct 30, 2020
Priority dateOct 30, 2020
Publication dateMay 5, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Multiple polynucleotides having different, arbitrary sequences are synthesized on the surface of an array by spatial control of polymerase activity. The polymerase is a template-independent polymerase such as terminal deoxynucleotidyl transferase (TdT). Spatial control of polymerase activity is implemented by localized changes in redox-pH conditions. A single species of nucleotide is added and incorporated on growing polynucleotide strands at locations on the array where the polymerase is active. A washing step removes the polymerase and free nucleotides. This process may be repeated multiple times changing both the location of polymerase activity and the species of nucleotide thereby synthesizing different polynucleotides in parallel on the surface of the array. Polymerase activity may be regulated by removing a blocking group attached to a His-tag sequence on the polymerase, a change in pH, or release of encapsulated inhibitors.

First claim

Opening claim text (preview).

1 . A method for enzymatic synthesis of polynucleotides comprising: (a) incubating an array having a plurality of initiators attached thereto with a reaction reagent solution comprising template-independent polymerase and with a selected species of nucleotide; and (b) altering redox-pH conditions at a selected location on the array such that activity of the template-independent polymerase is changed, without changing availability of a metal cofactor complexed with the template-independent polymerase. 2 . The method of claim 1 , wherein: the template-independent polymerase includes a His-tag sequence, the reaction reagent solution comprises blocking groups covalently modified with ligands and divalent metal cations that complex with the His-tag sequence and with the ligand, and wherein altering the redox-pH conditions comprises altering redox conditions such that an oxidation state of the divalent metal cation changes thereby releasing the blocking groups from complexes with the template-independent polymerase and increasing activity of the template-independent polymerase at the selected location. 3 . The method of claim 1 , wherein the reaction reagent solution has an unsuitable pH for the template-independent polymerase, and wherein altering the redox-pH conditions comprises altering pH conditions to an optimum pH for the template-independent polymerase thereby increasing activity of the template-independent polymerase at the selected location. 4 . The method of claim 1 , wherein the reaction reagent solution comprises encapsulated inhibitors, and wherein altering the redox-pH conditions comprise altering pH conditions such that inhibitors are released from encapsulation at the selected location thereby decreasing activity of the template-independent polymerase at the selected location. 5 . The method of claim 1 , wherein the array comprises a microelectrode array having a plurality of individually addressable electrodes and altering the redox-pH conditions at the selected location on the array comprises activating at least one of the individually addressable electrodes at the selected location. 6 . The method of claim 1 , wherein the reaction reagent solution further comprises photoredox catalysts and altering the redox-pH conditions at the selected location on the array comprises exposing the selected location on the array to a wavelength of light that excites the photoredox catalyst. 7 . The method of claim 1 , wherein altering the redox-pH conditions at the selected location on the array comprises delivering a chemical redox reagent, an acid, or a base, to the selected location with targeted fluid deposition instrument. 8 . The method of claim 1 , wherein the selected species of nucleotide comprises unmodified nucleotides. 9 . The method of claim 1 , further comprising: (c) contacting the array with a wash solution that removes the reaction reagent solution. 10 . The method of claim 9 , further comprising iteratively repeating steps (a), (b), and (c) such that both the selected location and the selected species of nucleotide change at least once between iterations. 11 . A method for enzymatic synthesis of a polynucleotide comprising: (a) incubating an array having a plurality of initiators attached thereto with a reaction reagent solution comprising inactive template-independent polymerase comprising a His-tag sequence complexed to a blocking group and with a selected species of nucleotide; and (b) altering redox conditions at a selected location on the array such that an oxidation state of a divalent metal cation complexed with the His-tag sequence changes thereby releasing the blocking group converting the inactive template-independent polymerase into active template-independent polymerase. 12 . The method of claim 11 , wherein the array comprises a microelectrode array having a plurality of individually addressable electrodes and altering the redox conditions at the selected location on the array comprises activating at least one of the individually addressable electrodes at the selected location. 13 . The method of claim 11 , wherein the reaction reagent solution further comprises photoredox catalysts and altering the redox conditions at the selected location on the array comprises exposing the selected location on the array to a wavelength of light that excites the photoredox catalysts. 14 . The method of claim 11 , wherein altering the redox conditions at the selected location on the array comprises delivering a chemical redox reagent to the selected location with a targeted fluid deposition instrument. 15 . The method of claim 11 , further comprising: (c) contacting the array with a wash solution that removes the reaction reagent solution; and iteratively repeating steps (a), (b), and (c) such that both the selected location and the selected species of nucleotide change at least once between iterations. 16 . A device for de novo synthesis of polynucleotides, the device comprising: an array having a plurality of initiators attached thereto; a first fluid delivery pathway configured to contact the array with a reaction reagent solution comprising a template-independent polymerase including a His-tag sequence complexed to a blocking group covalently modified with a ligand; a second fluid delivery pathway configured to contact the array with a selected species of nucleotide; and control circuitry configured to alter redox conditions at a selected location on the array changing an oxidation state of divalent metal cations complexed to the His-tag sequence thereby releasing the blocking group from the template-independent polymerase and to selectively open the first fluid delivery pathway and the second fluid delivery pathway. 17 . The device of claim 16 , further comprising: a third fluid delivery pathway configured to contact the array with a second selected species of nucleotide; and a computing device communicatively coupled to the control circuitry and configured to sequentially activate a redox-pH control mechanism and sequentially open the second fluid delivery pathway and the third fluid delivery pathway according to a preprogrammed sequence. 18 . The device of claim 16 , wherein the array comprises a microelectrode array having a plurality of individually addressable electrodes and the control circuitry is configured to alter redox conditions by activating at least one of the individually addressable electrodes at the selected location. 19 . The device of claim 16 , wherein the reaction reagent solution further comprises photoredox catalysts and further comprising a light source configured to direct light to the photoredox catalysts at the selected location on the array. 20 . The device of claim 16 , further comprising a targeted fluid deposition instrument configured to deliver a redox reagent to the selected location on the array.

Assignees

Inventors

Classifications

  • Nucleic acid amplification reactions · CPC title

  • DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title

  • C12P19/34Primary

    Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

  • DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022136021A1 cover?
Multiple polynucleotides having different, arbitrary sequences are synthesized on the surface of an array by spatial control of polymerase activity. The polymerase is a template-independent polymerase such as terminal deoxynucleotidyl transferase (TdT). Spatial control of polymerase activity is implemented by localized changes in redox-pH conditions. A single species of nucleotide is added and …
Who is the assignee on this patent?
Microsoft Technology Licensing Llc
What technology area does this patent fall under?
Primary CPC classification C12P19/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu May 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).